Mutations in Leucine-Rich Repeat Kinase 2 (LRRK2) are strongly associated with sporadic and autosomal-dominant late-onset Parkinson’s disease (PD) [1,2]. This evidence concerns the gene LRRK2 and Parkinson disease.